Abstract

The mutation risk of a DNA locus depends on its oligonucleotide context. In turn, mutability of oligonucleotides varies across individuals, due to exposure to mutagenic agents or due to variable efficiency and/or accuracy of DNA repair. Such variability is captured by mutational signatures, a mathematical construct obtained by a deconvolution of mutation frequency spectra across individuals. There is a need to enhance methods for inferring mutational signatures to make better use of sparse mutation data (e.g., resulting from exome sequencing of cancers), to facilitate insight into underlying biological mechanisms, and to provide more accurate mutation rate baselines for inferring positive and negative selection. We propose a conceptualization of mutational signatures that represents oligonucleotides via descriptors of DNA conformation: base pair, base pair step, and minor groove width parameters. We demonstrate how such DNA structural parameters can accurately predict mutation occurrence due to DNA repair failures or due to exposure to diverse mutagens such as radiation, chemical exposure, and the APOBEC cytosine deaminase enzymes. Furthermore, the mutation frequency of DNA oligomers classed by structural features can accurately capture systematic variability in mutagenesis of >1,000 tumors originating from diverse human tissues. A nonnegative matrix factorization was applied to mutation spectra stratified by DNA structural features, thereby extracting novel mutational signatures. Moreover, many of the known trinucleotide signatures were associated with an additional spectrum in the DNA structural descriptor space, which may aid interpretation and provide mechanistic insight. Overall, we suggest that the power of DNA sequence motif-based mutational signature analysis can be enhanced by drawing on DNA shape features.

Highlights

  • Advances in analysis of mutation signatures are transforming genomics of cancer [1,2,3,4,5], human populations [6], and model organisms [7]

  • DNA polymerase epsilon (POLE) in another colorectal cancer sample bearing a S297F hotspot mutation; (iii) a bladder tumor sample bearing the mutational signature of the APOBEC cytosine deaminase [23]; (iv) a lung adenocarcinoma sample highly enriched with the tobacco smoking mutational signature; (v) ultraviolet (UV) light-induced mutagenesis in a melanoma sample; and (vi) the hypermutation induced by therapy by the DNA methylating drug temozolomide (TMZ) in a glioblastoma sample

  • Our work highlights the ability of DNA shape features to predict mutational risk of individual genomic loci in cancers exposed to various mutagenic processes, ranging from DNA repair failures to mutagenic chemicals or radiation

Read more

Summary

Introduction

Advances in analysis of mutation signatures are transforming genomics of cancer [1,2,3,4,5], human populations [6], and model organisms [7]. Mutational signatures based on DNA shape parameters. Research and Innovation Horizon 2020 (20142020), under the Marie Skłodowska-Curie PROBIST grant agreement No 754510 (to A.K. and J.L., PROBIST co-fund fellowship of the Barcelona Institute of Science and Technology) and by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 757700, to F.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.